Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.034
Buy
RSI(14)
54.290
Neutral
STOCH(KDJ)(9,3,3)
77.826
Buy
ATR(14)
0.672
High Vlolatility
CCI(14)
56.483
Neutral
Williams %R
19.574
Overbought
TRIX(12,20)
-0.056
Sell
StochRSI(14)
71.458
Neutral
Elanco Animal Health Inc
ELAN22.305USD
+0.215+0.97%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
11.08BMarket Cap
308.38P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Elanco Animal Health Inc
Currency: USD Updated: 2025-12-19Key Insights
Elanco Animal Health Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24/158 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 25.15.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Elanco Animal Health Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
16
analysts
Buy
Current Rating
25.154
Target Price
+15.97%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Elanco Animal Health Inc Highlights
StrengthsRisks
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 308.31, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 577.24M shares, increasing 0.01% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 602.56K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.06.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Elanco Animal Health Inc is 7.14, ranking 128/158 in the Pharmaceuticals industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 1.14B, representing a year-over-year increase of 10.39%, while its net profit experienced a year-over-year increase of 109.34%.
Score
Financials
6.03
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
2.69
Operational Efficiency
10.00
Growth Potential
9.47
Shareholder Returns
7.50
Elanco Animal Health Inc's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Elanco Animal Health Inc is 7.41, ranking 72/158 in the Pharmaceuticals industry. Its current P/E ratio is 308.31, which is 5.07% below the recent high of 323.93 and 169.54% above the recent low of -214.39.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 24/158
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of Elanco Animal Health Inc is 8.53, ranking 27/158 in the Pharmaceuticals industry. The average price target for Elanco Animal Health Inc is 25.00, with a high of 30.00 and a low of 18.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
25.154
Target Price
+15.97%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
62
Total
5
Median
6
Average
Company name
Ratings
Analysts
Elanco Animal Health Inc
ELAN
16
Apple Inc
AAPL
50
Ge Vernova Inc
GEV
34
FMC Corp
FMC
21
Tapestry Inc
TPR
21
Verisk Analytics Inc
VRSK
20
1
2
3
...
13
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Elanco Animal Health Inc is 8.87, ranking 54/158 in the Pharmaceuticals industry. Currently, the stock price is trading between the resistance level at 23.86 and the support level at 20.57, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
22.132
Buy
MA10
21.664
Buy
MA20
22.158
Buy
MA50
21.837
Buy
MA100
19.986
Buy
MA200
16.060
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Elanco Animal Health Inc is 10.00, ranking 1/158 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 120.43%, representing a quarter-over-quarter decrease of 1.24%. The largest institutional shareholder is Van Duyn Dodge & E. Morris Cox, holding a total of 82.76M shares, representing 16.66% of shares outstanding, with 0.24% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Fidelity Management & Research Company LLC
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
Dimensional Fund Advisors, L.P.
UBS Financial Services, Inc.
State Street Investment Management (US)
Fidelity Institutional Asset Management
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Elanco Animal Health Inc is 7.66, ranking 38/158 in the Pharmaceuticals industry. The company's beta value is 1.87. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.87
VaR
+3.76%
240-Day Maximum Drawdown
+35.04%
240-Day Volatility
+46.09%
Return
Best Daily Return
60 days
+4.76%
120 days
+18.14%
5 years
+26.29%
Worst Daily Return
60 days
-5.81%
120 days
-5.81%
5 years
-20.59%
Sharpe Ratio
60 days
+2.26
120 days
+2.47
5 years
+0.02
Risk Assessment
Maximum Drawdown
240 days
+35.04%
3 years
+56.10%
5 years
+78.00%
Return-to-Drawdown Ratio
240 days
+2.48
3 years
+0.36
5 years
-0.09
Skewness
240 days
+2.91
3 years
+1.75
5 years
+1.27
Volatility
Realised Volatility
240 days
+46.09%
5 years
+43.14%
Standardised True Range
240 days
+2.43%
5 years
+2.72%
Downside Risk-Adjusted Return
120 days
+547.76%
240 days
+547.76%
Maximum Daily Upside Volatility
60 days
+22.71%
Maximum Daily Downside Volatility
60 days
+22.21%
Liquidity
Average Turnover Rate
60 days
+1.41%
120 days
+1.30%
5 years
--
Turnover Deviation
20 days
+105.66%
60 days
+31.45%
120 days
+21.22%
Peer Comparison
Pharmaceuticals
Elanco Animal Health Inc
ELAN
8.14 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Mirum Pharmaceuticals Inc
MIRM
8.80 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Regeneron Pharmaceuticals Inc
REGN
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Prestige Consumer Healthcare Inc
PBH
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Gilead Sciences Inc
GILD
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
ANI Pharmaceuticals Inc
ANIP
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Elanco Animal Health Inc?
The TradingKey Stock Score provides a comprehensive assessment of Elanco Animal Health Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Elanco Animal Health Inc’s performance and outlook.
How do we generate the financial health score of Elanco Animal Health Inc?
To generate the financial health score of Elanco Animal Health Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Elanco Animal Health Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Elanco Animal Health Inc.
How do we generate the company valuation score of Elanco Animal Health Inc?
To generate the company valuation score of Elanco Animal Health Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Elanco Animal Health Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Elanco Animal Health Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Elanco Animal Health Inc.
How do we generate the earnings forecast score of Elanco Animal Health Inc?
To calculate the earnings forecast score of Elanco Animal Health Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Elanco Animal Health Inc’s future.
How do we generate the price momentum score of Elanco Animal Health Inc?
When generating the price momentum score for Elanco Animal Health Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Elanco Animal Health Inc’s prices. A higher score indicates a more stable short-term price trend for Elanco Animal Health Inc.
How do we generate the institutional confidence score of Elanco Animal Health Inc?
To generate the institutional confidence score of Elanco Animal Health Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Elanco Animal Health Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Elanco Animal Health Inc.
How do we generate the risk management score of Elanco Animal Health Inc?
To assess the risk management score of Elanco Animal Health Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Elanco Animal Health Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Elanco Animal Health Inc.
